Chiara Caparello - Concepedia

Author

Chiara Caparello

Azienda Ospedaliera Universitaria Pisana

Also Known As

C Caparello, C. CAPARELLO, C. Caparello, C.F. Caparello, Caparello, Chiara, Chiara Caparello, Iacopo Chiodini, Michele Milella

102

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Azienda Ospedaliera Universitaria Pisana University of Pisa University of Bologna IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola National Yang Ming Chiao Tung University

About

Chiara Caparello is an author at Azienda Ospedaliera Universitaria Pisana specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	462
2	Pathology	3	3	112
3	Health Sciences	1	1	22
4	Gastroenterology	1	1	46
5	Hepatology	1	1	22

Chiara Caparello

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Outcomes of sequential treatment with sorafenib followed by regorafenib for HCC: Additional analyses from the phase III RESORCE trial Richard S. Finn, Philippe Merle, Alessandro Granito, Journal of Hepatology Additional AnalysesOncologyMedicineClinical TrialsSequential Treatment	2018	350
PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC Marzia Del Re, Riccardo Marconcini, G. Pasquini, British Journal of Cancer	2018	242
Early changes in plasma DNA levels of mutant KRAS as a sensitive marker of response to chemotherapy in pancreatic cancer Marzia Del Re, Caterina Vivaldi, Eleonora Rofi, Scientific Reports	2017	88
Plasma miR-181a-5p Downregulation Predicts Response and Improved Survival After FOLFIRINOX in Pancreatic Ductal Adenocarcinoma Laura L. Meijer, Ingrid Garajová, Chiara Caparello, Annals of Surgery	2018	70
Histopathologic evaluation of liver metastases from colorectal cancer in patients treated with FOLFOXIRI plus bevacizumab Fotios Loupakis, Marta Schirripa, Chiara Caparello, British Journal of Cancer	2013	60
A pneumatic dilation strategy in achalasia: prospective outcome and effects on oesophageal motor function in the long term I. Bravi, M. T. Nicita, Piergiorgio Duca, Alimentary Pharmacology & Therapeutics	2010	52
First‐line treatment with FOLFOXIRI for advanced pancreatic cancer in clinical practice: Patients' outcome and analysis of prognostic factors Caterina Vivaldi, Chiara Caparello, Gianna Musettini, International Journal of Cancer Surgical OncologyFirst‐line TreatmentGastroenterologyPathologySurgery	2016	46
Adjuvant chemotherapy seems beneficial for invasive intraductal papillary mucinous neoplasms S. Caponi, Enrico Vasile, Niccola Funel, European Journal of Surgical Oncology Surgical OncologyMedicineCancer ManagementAdjuvant ChemotherapyPathology	2013	44
Outcomes with sorafenib (SOR) followed by regorafenib (REG) or placebo (PBO) for hepatocellular carcinoma (HCC): Results of the international, randomized phase 3 RESORCE trial. Richard S. Finn, Philippe Merle, Alessandro Granito, Journal of Clinical Oncology Last Sor DoseClinical EndpointPathologyPharmacotherapyLogistic Analysis	2017	22
EGFR and AKT1 overexpression are mutually exclusive and associated with a poor survival in resected gastric adenocarcinomas Iacopo Petrini, Monica Lencioni, Enrico Vasile, Cancer Biomarkers	2017	19

Page 1